Literature DB >> 4842251

Effect of the antiestrogen C1628 on the growth of rat mammary tumors.

E R DeSombre, L Y Arbogast.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4842251

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

Review 1.  The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens.

Authors:  D A Tonetti; V C Jordan
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

2.  Endocrine adjuvant therapy in breast cancer.

Authors:  B A Stoll
Journal:  Br Med J       Date:  1976-10-30

3.  Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.

Authors:  S J Zimniski; M E Brandt; D F Covey; D Puett
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[]anthracene-induced mammary carcinoma: studies with slow-release formulations.

Authors:  K Stoeckemann; J Sandow
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  17α-ethynyl-5α-androstane-3α, 17β-diol treatment of MNU-induced mammary cancer in rats.

Authors:  Clarence N Ahlem; James M Frincke; Steven K White; Christopher L Reading; Richard J Trauger; Rajkumar Lakshmanaswamy
Journal:  Int J Breast Cancer       Date:  2011-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.